4//SEC Filing
STUELPNAGEL JOHN R 4
Accession 0001567619-22-000366
CIK 0001770787other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 6:13 PM ET
Size
7.2 KB
Accession
0001567619-22-000366
Insider Transaction Report
Form 4
STUELPNAGEL JOHN R
Director
Transactions
- Sale
Class A Common Stock
2021-12-30$150.56/sh−3,218$484,501→ 343,398 total - Sale
Class A Common Stock
2021-12-30$151.56/sh−1,782$270,089→ 341,616 total
Footnotes (3)
- [F1]The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $150.00 to $150.98. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F3]This transaction was executed in multiple trades at prices ranging from $151.02 to $151.98. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Documents
Issuer
10x Genomics, Inc.
CIK 0001770787
Entity typeother
Related Parties
1- filerCIK 0001189140
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 6:13 PM ET
- Size
- 7.2 KB